Data as of May 17
| -0.03 / -0.92%|
The 2 analysts offering 12-month price forecasts for Sinovac Biotech Ltd have a median target of 3.70, with a high estimate of 4.00 and a low estimate of 3.40. The median estimate represents a +14.55% increase from the last price of 3.23.
The current consensus among 2 polled investment analysts is to Hold stock in Sinovac Biotech Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.